Clinical Trial Update: Identification of a Plasma Proteomic Signature for Lung Cancer

View source ↗

Summary

This clinical trial update reports identification of a plasma proteomic signature associated with lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Integrated Diagnostics | Conditions: Precancerous Conditions, Carcinoma | Status: COMPLETED